NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Metagenomi, Inc. (NASDAQ: MGX). Shareholders who purchased shares of MGX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/metagenomi-loss-submission-form/?id=108485&from=3 CLASS PERIOD: This lawsuit is on ...

PHILADELPHIA, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Metagenomi Inc. ("Metagenomi" or the "Company") (NASDAQ: MGX) on behalf of purchasers of Metagenomi securities between February 6, 2024 and September 26, 2024, inclusive (the "Class Period"). Investors that suffered losses from METAGENOMI (NASDAQ: MGX) investments can follow the link below for more information regarding the lawsuit: CLICK HERE to learn more abo ...

文章核心观点 - 公司开发了一种新型的紧凑型SMART腺嘌呤碱基编辑器(ABE),可以被包装进单一的腺相关病毒(AAV)载体中 [1][2] - 这种SMART系统优化后的编辑效率有所提高,可以应用于治疗相关的基因编辑 [2] - 公司采取了多种方法来优化SMART平台,包括结构指导工程和人工智能工具 [3] 公司概况 - 公司是一家专注于开发治愈性基因治疗的精准医疗公司 [4] - 公司利用大规模基因组学技术发现和开发了一系列新型的基因编辑工具,包括可编程核酸酶、碱基编辑器和集成系统 [4] - 公司相信其多样化和模块化的工具箱可以访问整个基因组,选择最佳工具来实现基因编辑的全部潜力 [4]

NEW YORK, Oct. 14, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Metagenomi, Inc. (NASDAQ: MGX). Shareholders who purchased shares of MGX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/metagenomi-loss-submission-form/?id=107873&from=4 CLASS PERIOD: This lawsuit is on beha ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Metagenomi To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Metagenomi between February 9, 2024 and September 26, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247- 4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Oct. 11, 202 ...

文章核心观点 - 美国纽约证券法律事务所Wolf Haldenstein Adler Freeman & Herz LLP宣布,已经代表在2024年2月6日至2024年9月26日期间购买或以其他方式获得Metagenomi Inc.(纳斯达克代码:MGX)证券的个人和实体,在美国加利福尼亚北区联邦地区法院提起证券集体诉讼 [1] - 该诉讼要求法院指定原告作为提议的集体诉讼的首席原告,并要求投资者在2024年11月25日之前联系该律所了解更多权利信息 [2] 公司相关 - Metagenomi公司于2024年2月9日进行了首次公开募股(IPO),发行了625万股普通股,每股价格为15美元 [2] - 2024年5月1日,Metagenomi公司宣布与Moderna公司"双方同意终止他们在原发性高氧尿症1型(PH1)上的合作",Metagenomi公司将获得PH1项目以及所有其他合作权利的归还 [3] - 这一消息公布后,Metagenomi公司的股价下跌了0.87美元或12.36%,收于每股6.17美元 [3] 律所相关 - Wolf Haldenstein律所在证券集体诉讼和衍生诉讼方面拥有丰富经验,在全国各地的州和联邦审讯法院和上诉法院进行过诉讼 [3] - 该律所拥有多个执业领域的律师,在纽约、芝加哥、纳什维尔和圣地亚哥设有办公室,在股东和其他集体诉讼方面的声誉和专业知识得到法院的多次认可 [3] - 投资者如果希望讨论此案或了解自己的权利和利益,可以立即通过电话或电子邮件与Wolf Haldenstein律所联系 [4]

NEW YORK, Oct. 10, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Metagenomi, Inc. (NASDAQ: MGX). Shareholders who purchased shares of MGX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/metagenomi-loss-submission-form/?id=107512&from=4 CLASS PERIOD: This lawsuit is on beha ...

NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Metagenomi, Inc. ("Metagenomi" or the "Company") (NASDAQ: MGX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Metagenomi investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all shareholders that purchased stock pursuant and/or traceable to Metagenomi's registration statement for the initial public offering held between F ...

SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities who purchased stock pursuant to and/or traceable to Metagenomi Inc.'s (NASDAQ: MGX) registration statement for the initial public offering (IPO) held between February 9 and 13, 2024. Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. For more information, ...

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Metagenomi, Inc. (NASDAQ: MGX). Shareholders who purchased shares of MGX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/metagenomi-loss-submission-form/?id=107041&from=3 CLASS PERIOD: This lawsuit is on ...